CDC Revises RSV Vaccination Recommendation for Older Adults in US

In 2023, the US Centers for Disease Control and Prevention (CDC) recommended the respiratory syncytial virus (RSV) vaccine for people aged 60 years or older after they’d talked over the decision with their physician. Recently, the agency announced it is updating those guidelines for older adults. Now, people aged 75 years or older should receive a single dose of the RSV vaccine along with adults aged 60 years to 74 years who live in nursing homes or have chronic medical conditions including lung or heart disease.